NCT00256282 - Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Metastatic Melanoma

Interventions

DRUG

Vinorelbine

30 mg/m2 IV over 6-10 min every 14 days

DRUG

Docetaxel

40mg/m2 IV over 1 hour every 14 days

DRUG

Sargramostim

250 mcg/m2 subcutaneous (SQ) daily (QD) x 10 days

Trial Locations (1)

Chao Family Comprehensive Cancer Center, Orange